TGFB1 and neuroblastic tumor: In the case of anti-inflammatory cytokines, we found significant associations between low serum levels of IL-10 and TGF-β and a decrease in the risk of presenting neuroblastic tumors in stage INSS 1 and 2 (Table 5).